US Edition
Roche Secures CE Mark for Blood Test to Aid in Ruling Out Alzheimer’s Disease
Summary by darkdaily.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Roche Secures CE Mark for Blood Test to Aid in Ruling Out Alzheimer’s Disease
Roche’s IVDR-certified Elecsys pTau181 blood test helps rule out Alzheimer’s early, supporting faster decisions in primary care. Roche has received CE Mark approval for its Elecsys pTau181 test, developed in collaboration with Eli Lilly. The test measures phosphorylated Tau 181 (pTau181), a biomarker associated with amyloid pathology—one of the hallmarks of Alzheimer’s disease. Clinicians can […] The post Roche Secures CE Mark for Blood Test to …
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
